134 related articles for article (PubMed ID: 5781103)
1. The role of the spleen in the immunity to a chemically induced sarcoma in C3H mice.
Bard DS; Pilch YH
Cancer Res; 1969 May; 29(5):1125-31. PubMed ID: 5781103
[No Abstract] [Full Text] [Related]
2. Increased resistance in splenectomized mice to a methylcholanthrene-induced tumour.
Chang RW; Turk JL
Br J Cancer; 1977 Jun; 35(6):768-76. PubMed ID: 871366
[TBL] [Abstract][Full Text] [Related]
3. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
Milas L; Hunter N; Mason K; Withers HR
Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
[No Abstract] [Full Text] [Related]
4. Discussion paper: in vitro augmentation of tumor immunity in a murine methylcholanthrene sarcoma system.
Yarlott MA; McKhann CF
Ann N Y Acad Sci; 1976; 277(00):533-40. PubMed ID: 187102
[No Abstract] [Full Text] [Related]
5. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
6. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
Ishikawa Y; Fukushima M; Sato T; Komaba M; Yagihashi H
Tohoku J Exp Med; 1971 Feb; 103(2):195-201. PubMed ID: 5580594
[No Abstract] [Full Text] [Related]
7. Changes in spleen morphology and lymphoid cell activity during tumor progression.
Yamagishi H; Pellis NR; Macek C; Kahan BD
Eur J Cancer (1965); 1980 Nov; 16(11):1417-26. PubMed ID: 7227418
[No Abstract] [Full Text] [Related]
8. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
[No Abstract] [Full Text] [Related]
9. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
Röllinghoff M; Warner NL
Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
[No Abstract] [Full Text] [Related]
10. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
Jurin M; Suit HD
Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
[No Abstract] [Full Text] [Related]
11. The antigenicity and immunogenicity of cell-free extracts of chemically induced murine sarcomas.
Pilch YH
Cancer Res; 1968 Dec; 28(12):2502-11. PubMed ID: 4302533
[No Abstract] [Full Text] [Related]
12. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
Vaage J
Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
[No Abstract] [Full Text] [Related]
13. Effect of anti-embryo immunization on methylcholanthrene-induced sarcoma growth in BALB/c mice.
Parmiani G; Lembo R
Int J Cancer; 1974 Oct; 14(4):555-64. PubMed ID: 4617712
[No Abstract] [Full Text] [Related]
14. Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase.
Simmons RL; Rios A; Ray PK
J Surg Oncol; 1972; 4(4):298-305. PubMed ID: 5083567
[No Abstract] [Full Text] [Related]
15. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
[No Abstract] [Full Text] [Related]
16. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
Simmons RL; Rios A
Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
[No Abstract] [Full Text] [Related]
17. Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay.
Gabizon A; Small M; Trainin N
Int J Cancer; 1976 Dec; 18(6):813-9. PubMed ID: 992909
[TBL] [Abstract][Full Text] [Related]
18. Tumor growth in the guinea pig: alpha globulin changes associated with lymphocyte suppression.
Lilley DP; Burger DR; Vetto RM
J Natl Cancer Inst; 1974 Sep; 53(3):701-9. PubMed ID: 4138027
[No Abstract] [Full Text] [Related]
19. The effect of tumor size on concomitant tumor immunity.
Deckers PJ; Davis RC; Parker GA; Mannick JA
Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
[No Abstract] [Full Text] [Related]
20. Transfer of immunity to tumour isografts by the systemic administration of xenogeneic "immune" RNA.
Deckers PJ; Pilch YH
Nat New Biol; 1971 Jun; 231(23):181-3. PubMed ID: 5281197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
